Welcome to P\S\L Group

Over 1 million visits a month
Click here to learn more

Doctors registered in 127 countries
Click here to learn more

AstraZeneca's Seroquel XR approved in Europe as add-on treatment - (Ref. Canadian Business; MarketWatch; Morningstar; Stock Markets Review; Yahoo!News; AstraZeneca) Takeda signs deal to sell Orexigen's obesity drug in North America - (Ref. Bloomberg; Canadian Business; MarketWatch; TheStreet.com; Xconomy; Orexigen Therapeutics; Takeda) Study: Abbott's Meridia increases heart attack, stroke risk in some patients - (Ref. Bloomberg; The Bellingham Herald; The Washington Post; USA Today; Yahoo!News; NEJM) Merck & Co., Cardiome's Brinavess receives EU approval - (Ref. FinanzNachrichten; NASDAQ; Stock Markets Review; Merck) Allergan to pay $600 million to settle investigation into marketing of Botox - (Ref. Bloomberg; Forexyard; MarketWatch; NASDAQ; Stock Markets Review; Allergan) More Industry News
Atopaxar With Standard Therapy May Reduce ACS and CAD Major Adverse Cardiac Events: Presented at ESC - (DGDispatch) Study Shows Oral Sucrose Does Not Relieve Pain in Newborns - (DGNews) Oral Phosphodiesterase Type-5 Inhibitors Promote Recovery of Urinary Continence After Radical Prostatectomy: Presented at ICS - (DGDispatch) Revaccination Could Benefit Children With HIV - (DGNews) Ultrasonographic Monitoring Beneficial to Evaluate Mesh Positions: Presented at ICS - (DGDispatch) More Medical News
Privacy Policy \| All contents Copyright© 2010 P\S\L Group. All rights reserved.